This is a full on sell by the Imugene team. They are hopingfor...

This is a full on sell by the Imugene team. They are hoping
for patients to fill the upcoming trial and the sooner that can
start, and results known, and if the results are as successful
as hoped, registrational trial or pharma deal could occur.
Impressive that Yuman will be present as the creator of the
technology; also held in America, this could be the catalyst
everyone is hoping for. Oncology drugs have not featured
much in the pharma buyouts or licences this year to date,
so with the increase in incidences of cancer, seems likely some
interest to acquire new treatments by pharmas is likely.